Farooq A. Bandali, PharmD, BCPS
|
|
|
- Kory Lane
- 10 years ago
- Views:
Transcription
1 Farooq A. Bandali, PharmD, BCPS CURRENT POSITIONS Clinical Assistant Professor Department of Pharmacy Practice and Administration Ernest Mario School of Pharmacy Rutgers, The State University of New Jersey 160 Frelinghuysen Road, Room 417A Piscataway, NJ (o): ext 5742 (f): Critical Care Clinical Pharmacist Saint Peter s University Hospital (SPUH) Department of Pharmaceutical Services 254 Easton Avenue New Brunswick, NJ (o): ext 5742 (f): [email protected] EDUCATION AND TRAINING Critical Care Pharmacy Residency; Medical University South Carolina; Charleston, South Carolina Pharmacy Practice Residency; Charleston Area Medical Center, Charleston, West Virginia Doctor of Pharmacy Degree; University of Texas at Austin, College of Pharmacy, Austin, Texas LICENSURE 2006 New Jersey (Active) 2001 Connecticut (Active) 2001 Texas (Active) CERTIFICATIONS 2008 Mini-MBA Program: Strategic Healthcare Management Program jointly sponsored by Rutgers, The State University of New Jersey and Saint Peter s University Hospital 2007 Board Certified Pharmacotherapy Specialist 2006 Academician Preparation (Teaching Certificate) Program, South Carolina College of Pharmacy
2 Farooq Bandali Curriculum Vitae Page 2 PROFESSIONAL EXPERIENCES Pharmacy Technician Program Lecturer Norwalk Community College Norwalk, Connecticut Staff/Clinical Pharmacist Bridgeport Hospital Bridgeport, Connecticut Staff Pharmacist CVS Pharmacy Fairfield, Connecticut TEACHING EXPERIENCES Clinical Assistant Professor Department of Pharmacy Practice and Administration Ernest Mario School of Pharmacy Rutgers, The State University of New Jersey Piscataway, NJ Clinical Preceptor Advanced Pharmacy Practice Experience for Doctor of Pharmacy students in the Medical/Surgical Intensive Care Unit (ICU) at Saint Peter s University Hospital. Precept students per year Didactic Teaching Critical Care Pharmacotherapy (31:725:582:01) Course Co-coordinator (2008-Present) Cardiogenic Shock (2011-Present) Neurocritical Care: Stroke and Traumatic Brain Injury (2011) Severe Sepsis & Neurogenic Shock: Learning through simulation (2011) Severe Sepsis & Ischemic Stroke: Learning through simulation (2012) Interpreting Arterial Blood Gases (ABG) (2010-Present) Common infections in the ICU I (2010-Present) Common infections in the ICU II (2010-Present) Introduction to Critical Care (2010, 2012) Therapeutic Drug Monitoring (2010) Shock syndromes ( ) Shock I: Basic concepts and vasoactive agent overview (2012-Present)
3 Farooq Bandali Curriculum Vitae Page 3 TEACHING EXPERIENCES (continued) Shock II: Cardiogenic and Hypovolemic Shock (2012-Present) Shock III: Distributive Shock Focus on Sepsis (2012-Present) Sedatives, analgesics & neuromuscular blockers (2007, 2008, 2010) Clinical management of sepsis (2007-Present) Delirium in the ICU (2007, 2008, 2009) Interactive Sessions (2008, 2009, 2012, 2013) Cardiopulmonary Therapeutics (30:725:460) Shock Syndromes (2007-Present) Advanced Pharmacotherapy Applications (31:725:579:01) Massive Pulmonary Embolism (2011, 2013) Severe Sepsis & Acute Coronary Syndrome: Learning via simulation (2010) Acute Coronary Syndrome and Cardiogenic Shock (2009) Heparin-induced thrombocytopenia (2008) 2005-Present Lecturer University of Florida, College of Pharmacy Working Professional PharmD Program (WPPD) Gainesville, Florida Women s Health and Endocrine & Hematologic Disorders (PHA5594) Managing Hyperglycemic Crisis in Diabetes (2007, 2010) Thyroid disease (2007, 2010) Circulatory Disorders (PHA5591) Managing Hypertensive Crisis (2006, 2007, 2009) Neurological and Psychiatric Disorders (PHA5598) Traumatic Brain Injury (2005) Meningitis (2005) CLINICAL PRACTICE Critical Care Clinical Pharmacist Saint Peter s University Hospital Department of Pharmaceutical Services New Brunswick, New Jersey Clinical duties include rounding with a multidisciplinary team, responding to code blue and code stroke calls, assisting the intensive care unit team to admit patients from the emergency room to the ICU, helping to establish clinical pharmacy services within the ICU setting with an emphasis on drug utilization, provision of drug information to healthcare professionals, and delivering educational presentations for nursing, pharmacy and medical staff.
4 Farooq Bandali Curriculum Vitae Page 4 CLINICAL PRACTICE (continued) Institution-wide Committee Involvement [extension of clinical practice] Chair, Antibiotic Subcommittee (Jan 2009-Present). In 2010, conducted a pilot antimicrobial stewardship program (ASP) in the ICU. Due to the success of the pilot program, a hospital-wide ASP was established in Chair, Anticoagulation Committee (Jan Present). Developed order sets, guidelines and policies to help with patient safety initiatives. These include argatroban, enoxaparin, heparin and warfarin order sets. Additional Order Sets/Guidelines/Policies/Medication Use Evaluation Developed (or assisted with) at SPUH Alteplase for Catheter-Directed Thrombolysis, Antibiogram reporting CRRT Order Set Ertapenem Medication Use Evaluation Heparin Medication Use Evaluation Intravenous Acetaminophen Medication Use Evaluation Pneumonia Order Set Sedation Order Set Severe Sepsis Order Set Surgical Care Infection Prevention (SCIP) Order Set Total Parenteral Nutrition Order Set Vancomycin Order Set Vasoactive Order Set Other Institution and ICU Committee Involvement [extension of clinical practice] Pneumonia Rapid Cycle Task Force (2010 Present) New Jersey Hospital Association (NJHA) Surviving Sepsis Campaign Committee (2008 Present) Critical Care Committee (2006 Present) Pharmacy and Therapeutics Committee (2006 Present) PRESENTATIONS National Presentations 2012 Bandali FA, Thomas Z, Sankaranarayan, J Reardon T, Olsen K. Prevalence and Factors Associated With Prolonged Surgical Prophylaxis: Analysis from the Prolonged Empiric Antibiotic Therapy Study presented at 42 nd Annual Congress for the Society of Critical Care Medicine (SCCM) Annual Congress in Houston, Texas
5 Farooq Bandali Curriculum Vitae Page 5 PRESENTATIONS (continued) 2012 Thomas Z, Bandali FA, Sankaranarayan, J Reardon T, Olsen K. A Multicenter Evaluation of Prolonged Empiric Antibiotic Therapy in Adult Intensive Care Units in the United States presented at 42 nd Annual Congress for the Society of Critical Care Medicine Annual Congress in Houston, Texas 2009 Neuropharmacology: Therapeutic Controversies in 2009 presented at the American Academy of Critical Care Nurses Annual Meeting held in New Orleans, LA 2009 Barbarello-Andrews L, Bandali FA, Pfeiffer CM. Assessment of Outcomes of a Unique Critical Care Elective Course presented at the 2009 Annual Meeting for the American Association of Colleges of Pharmacy in Boston, MA 2008 Recombinant Factor VIIa in Acute Intracerebral Haemorrhage (FAST) Trial presented at the National Mayo Clinic Journal Club (Teleconference) Regional Presentations 2012 Emerging anticoagulants in atrial fibrillation: Will warfarin become the thing of the past? Presented to pharmacists for Rutgers Anticoagulation Continuing Education (CE) Seminar 2011 Managing Gram Negative Infections: Past, Present and Future Presented to pharmacists for Rutgers Infectious Disease CE Seminar 2011 Multi-Drug Resistance: What a Dilemma! Presented to pharmacists for Rutgers Infectious Disease CE Seminar 2010 Management of Intracerebral and Subarachnoid hemorrhage Presented to pharmacists for Rutgers Stroke CE Seminar 2010 Proton Pump Inhibitors: The Good, The Bad & The Controversial Presented to pharmacists for Rutgers CE Seminar 2009 Managing Type II Diabetes: In Search Of A New Paradigm Presented to pharmacists at Sanofi-Aventis, Bridgewater, New Jersey for Rutgers Diabetes CE seminar 2009 Inpatient Management of Venous Thromboembolism Presented to pharmacist for the Roy Bowers CE Seminar 2008 The Role of the Clinical Pharmacist in the Hospital Setting Presented at Kean University to students in the Masters of Science, Technology & Mathematics Education program 2008 Striking Back at HIT: What a pharmacist should know? Presented to pharmacists for the Rutgers Cardiology CE Seminar
6 Farooq Bandali Curriculum Vitae Page 6 PRESENTATIONS (continued) 2008 Managing Pneumonia: What A Clinical Enigma Presented to Rutgers Infectious Disease CE Seminar 2008 Glitazones and Cardiotoxicity: Pandora s Box has been opened! Presented to pharmacists and pharmacy students for Rutgers Cardiology CE Seminar 2007 Striking Back at HIT: What a pharmacist should know? Presented to pharmacists for Rutgers Cardiology CE Seminar SPUH Medical, Surgical and Nursing Grand Rounds Seminar 2013 Inpatient Management of Venous Thromboembolism (VTE) 2013 Hypertension & Stroke: The Role of the Nurse 2013 Antimicrobial Stewardship: Achieving Success Through A Collaborative Approach 2012 Emerging anticoagulants in atrial fibrillation: Pearls for the Beside Practitioner 2010 TPA & BP Management in Acute Ischemic Stroke (AIS): The Role of The Nurse Pressure Ulcers in the ICU: A Critical Dilemma 2009 Critical Care: Therapeutic Controversies in Recombinant Factor VIIa (rfviia) in Postpartum hemorrhage (PPH): Evidencebase or experience-base medicine? 2007 Brain bleed secondary to rat poison : Is PCC or rfviia the magical antidote? SPUH Institutional Presentations to Physicians, Pharmacists and Nurses 2012 Emerging anticoagulants in atrial fibrillation: Pearls for the Practitioner 2012 Antimicrobial Stewardship Program: What is the opportunity at SPUH? 2012 Dexmedetomidine (Precedex ): Finding Where It Fits 2012 Shock Syndromes 2010 Striking back at Heparin induced thrombocytopenia (HIT): A Therapeutic Update 2010 Shock Syndromes 2010 Clinical Application of Vancomycin and SPUH Guidelines 2009 Sedation, Analgesia & Neuromuscular Blockers 2009 Striking back at Heparin-Induced thrombocytopenia (HIT): A Therapeutic Update 2009 Shock Syndromes 2008 The Role of Acid Suppression in the Hospitalized Patients 2008 Striking back at Heparin-Induced thrombocytopenia (HIT): What a physician should know? 2008 Treating MRSA: Update and Clinical Application of Vancomycin
7 Farooq Bandali Curriculum Vitae Page Shock Syndromes 2008 Managing Delirium in the Intensive Care Unit 2007 Striking back at Heparin-Induced thrombocytopenia (HIT): What a physician should know? 2006 Preventing Errors Related to Fluid and Electrolyte Management: The Role of the Pharmacist PEER-REVIEWED PUBLICATIONS Brunetti L, Bandali F. Dabigatran: is there a role for coagulation assays in guiding therapy? Ann Pharmacother Jun;47(6): Thomas Z, Bandali FA, McCowen KC, Malhotra A. Drug-induced endocrine disorders in the Intensive Care Unit. Crit Care Med. 2010;38:S Bandali, FA and Thomas Z. Recombinant Factor VIIa in Intracerebral Hemorrhage. Hospital Pharmacy February 2008; 43 (2): BOOK CHAPTER Thomas Z, Bandali F. Drug-Induced Endocrine Disorders. In: Papadopoulos J, Cooper B, Corbett SM, Kane-Gill S, eds. Drug-Induced Complications in the Critically Ill Patient: A Guide for Recognition and Treatment. Mount Prospect, IL: Society of Critical Care Medicine; 2012 ABSTRACTS Bauer S, Thomas Z, Bandali F, Kane-Gill S, Voils S, Lat I. Growth of A Pharmacist-Led Critical Care Practice-Based Research Network: the Critical Care Pharmacotherapy Trials Network [abstr]. Crit Car Med 2012;40:A152S. Bandali F, Thomas Z, Sankaranarayanan J, Reardon T, Olsen K. Prevalence and Factors Associated With Prolonged Surgical Prophylaxis: Analysis From the Prolonged Empiric Antibiotic Therapy Study [abstr]. Crit Car Med 2011;39:A297S. Thomas Z, Bandali F, Sankaranarayanan J, Reardon T, Olsen K. A Multicenter Evaluation of Prolonged Empiric Antibiotic Therapy in Adult Intensive Care Units in the United States [abstr]. Crit Car Med 2011;39:A291S. Barbarello-Andrews L, Bandali FA, Pfeiffer CM. Assessment of Outcomes of a Unique Critical Care Elective Course poster presentation at the 2009 Annual Meeting for the American Association of Colleges of Pharmacy in Boston, MA
8 Farooq Bandali Curriculum Vitae Page 8 CONTRIBUTOR FOR SCCM DRUG SHORTAGE TASK FORCE 2012 Drug Shortage Alert: Intravenous Sodium Bicarbonate ortagesummary1_final%20%282%29.pdf ABSTRACT REVIEWER Present Society of Critical Care Medicine Annual Congress ADVISORY BOARD 2012 Ikaria Therapeutics LLC 2009 ProEd Communications, Inc LEGAL CASE REVIEW 2013 Expert opinion provided for Birdsall & Laughlin, LLC 1720 Highway 34 Wall Township, New Jersey RESEARCH Characterizing Antimicrobial Use in the Critically ill and Determination of the Prevalence of Prolonged Empiric Antibiotic Therapy co-primary investigator 2007 The Prevalence of Off-label Medication Use in Adult Critical Care in the United States. Sponsor: Society of Critical Care Medicine/Clinical Pharmacy and Pharmacology Network Site Investigator GRANTS 2011 Thermo Scientific Biomarkers: Awarded $5000 for an unrestricted medical education grant for the Continuing Education Program at Rutgers titled Clinical Pearls in Infectious Disease SERVICE National Organizations 2012-Present 2012-Present Appointed Member, SCCM Drug Shortage Task Force Member, Program Committee, SCCM Clinical Pharmacy and Pharmacology (CPP) Section
9 Farooq Bandali Curriculum Vitae Page Present 2011-Present Member, Communications Committee, SCCM CPP Section Member, Program Committee, American College of Clinical Pharmacy (ACCP) 2010 Chair, Research Committee, SCCM CPP Section 2009 Co-Chair Research Committee, SCCM CPP Section 2008 Member, SCCM, CPP Research Committee 2012-Present 2011-Present Rutgers, The State University Of New Jersey Rho Chi Advisor Member, Accreditation Council for Pharmacy Education (ACPE) Self-Study Mission, Planning and Evaluation Working Group Admissions and Recruitment Committee 2010-Present Academic Integrity Committee 2007 Present Continuing Education (CE) Committee Programs Co-Coordinator for the Rutgers CE Committee 2012 Anticoagulants and Antiplatelets Getting To the Heart of the Matter 2012 Clinical Pearls in Infectious Disease 2011 Infectious Diseases in 2011: A Major Public Health Concern 2011 Therapeutic Updates: What Every Pharmacist Should Know 2009 Infection Disease CE Seminar 2008 Cardiology CE Seminar AFFILIATIONS/MEMBERSHIPS 2011-Present 2011-Present 2005-Present 2003-Present New Jersey Society of Health-System Pharmacist American Association of Colleges of Pharmacy Member, Society of Critical Care Medicine Member, American College of Clinical Pharmacy Member, American Society of Health-System Pharmacists HONORS AND AWARDS 2011 Presidential Citation, Society of Critical Care Medicine
Curriculum Vitae. 2100 Statonsburg Road (252)847-5875
Curriculum Vitae 2100 Statonsburg Road (252)847-5875 Greenville, NC 27834 [email protected] Education/Training PGY2 Specialty Practice Residency, Cardiology July 2009-June 2010 Columbus, OH PGY1
ALEXIS ANDERSON 280 Calhoun Street MSC 132, Charleston, SC 29425
ALEXIS ANDERSON 280 Calhoun Street MSC 132, Charleston, SC 29425 EDUCATION AND TRAINING PGY1 Pharmacy Residency 2009-2010 Medical University of South Carolina Medical Center and College of Pharmacy ASHP-Accredited
Brigham and Women s Hospital PGY-2 Critical Care Pharmacy Residency
Hospital and Department Overview Brigham and Women s Hospital, located in Boston s Longwood Medical Area, is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners
Licensure. Registered Pharmacist New York - License number 043093. Certifications. WMD Cardiology ACLS / PALS Pharmacist Immunizer
Danielle Longo, BS, RPh, PharmD 19 Noble Street Lynbrook, NY 11563 Home: 516-887-4998 Cell: 917-922-9550 Fax: 516-887-1110 [email protected] [email protected] Licensure Certifications Registered
APPENDIX B SAMPLE PEDIATRIC CRITICAL CARE NURSE PRACTITIONER GOALS AND OBJECTIVES
APPENDIX B SAMPLE PEDIATRIC CRITICAL CARE NURSE PRACTITIONER GOALS AND OBJECTIVES The critical care nurse practitioner orientation is an individualized process based on one s previous experiences and should
BOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC 20037-2985 202-429-7591 FAX 202-429-6304 [email protected] www.bpsweb.
BOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC 20037-2985 202-429-7591 FAX 202-429-6304 [email protected] www.bpsweb.org Content Outline for the CRITICAL PHARMACY SPECIALTY CERTIFICATION
PGY-1 General Pharmacy Practice Residency (Inpatient & Outpatient)
(Inpatient & Outpatient) PGY-1 pharmacy residency programs at the William S. Middleton Veterans Hospital (also known as the Madison VA ) have been in existence for 30 years and Art Schuna has trained over
Residency Preceptor Biographies *indicates member of the Residency Advisory Council
Residency Preceptor Biographies *indicates member of the Residency Advisory Council University of Georgia College of Pharmacy Kalen B. Manasco, Pharm.D., BCPS, AE-C (Residency Program Director, General
BAPTIST MEDICAL CENTER JACKSONVILLE
BAPTIST MEDICAL CENTER JACKSONVILLE Baptist Medical Center Jacksonville, a 444-bed tertiary hospital that is the flagship of Baptist Health in Jacksonville, Florida, is centrally located on the south bank
Course Curriculum for Master Degree in Clinical Pharmacy
Course Curriculum for Master Degree in Clinical Pharmacy The Master Degree in Clinical Pharmacy is awarded by the Faculty of Graduate studies at Jordan University of Science and Technology (JUST) upon
Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Long-term prevention of venous blood clots (VTE): Bayer Initiates Rivaroxaban
Philosophy: General Description: Program Goals:
Philosophy: Specialty Residency in Geriatric Pharmacy Practice Program Director: Amie Taggart Blaszczyk, Pharm.D., CGP, BCPS, FASCP North Texas Veterans Health Care System & Texas Tech University Health
Stop the Bleeding: Management of Drug-induced Coagulopathy. Stacy A. Voils, PharmD, BCPS Critical Care Specialist, Neurosurgery
Stop the Bleeding: Management of Drug-induced Coagulopathy Stacy A. Voils, PharmD, BCPS Critical Care Specialist, Neurosurgery Objectives Discuss contemporary management of warfarin reversal in patients
DVT/PE Management with Rivaroxaban (Xarelto)
DVT/PE Management with Rivaroxaban (Xarelto) Rivaroxaban is FDA approved for the acute treatment of DVT and PE and reduction in risk of recurrence of DVT and PE. FDA approved indications: Non valvular
Recommendations: Other Supportive Therapy of Severe Sepsis*
Recommendations: Other Supportive Therapy of Severe Sepsis* K. Blood Product Administration 1. Once tissue hypoperfusion has resolved and in the absence of extenuating circumstances, such as myocardial
Residency Program Faculty Biographies
Kingsbrook Jewish Medical Center The Kingsbrook Jewish Medical Center/David Minkin Rehabilitation Center (KJMC/DMRI) is an 784 bed teaching, medical and pharmacy university affiliated, non profit, private
New Oral Anticoagulants. How safe are they outside the trials?
New Oral Anticoagulants How safe are they outside the trials? Objectives The need for anticoagulant therapy Indications for anticoagulation Traditional anticoagulant therapies Properties of new oral anticoagulants
PGY-2 ONCOLOGY PHARMACY RESIDENCY
PGY-2 ONCOLOGY PHARMACY RESIDENCY Program Description and Requirements Providence Health System (PAMC) in Anchorage consists of 394 acute care beds and is part of an integrated health system including
AZZAH S. ZAIDI PROFESSIONAL PROFILE AREAS OF EXPERTISE PROFESSIONAL EXPERIENCE
AZZAH S. ZAIDI PROFESSIONAL PROFILE Strong interpersonal skills with a proven track record of establishing robust relationships with patients, medical professionals, pharmacy programs, healthcare organizations
Monash University - Master of Clinical Pharmacy
Monash University - Master of Clinical The Master of Clinical is a 48 credit point program, equivalent to one year of full time study (generally completed in 2 years part time). It comprises 1200 hours
LEARN, DO, TEACH utoledo.edu/pharmacy/residency
THE UNIVERSITY OF TOLEDO Pharmacy Residencies THE UNIVERSITY OF TOLEDO Recognized as an institution of excellence for more than 150 years, The University of Toledo expanded upon this reputation by merging
CURRICULUM VITAE. NAME: Stephen Harold Arnold Hernandez, PhD, RN
CURRICULUM VITAE NAME: Stephen Harold Arnold Hernandez, PhD, RN CONTACT INFORMATION: Address UNM College of Nursing MSC09 5350 1 University of New Mexico Albuquerque, New Mexico 87131-0001 Office Phone
Low Molecular Weight Heparin. All Wales Medicines Strategy Group (AWMSG) Recommendations and advice
Low Molecular Weight Heparin All Wales Medicines Strategy Group (AWMSG) Recommendations and advice Starting Point Low Molecular Weight Heparin (LMWH): Inhibits factor Xa and factor IIa (thrombin) Small
The author has no disclosures
Mary Bradbury, PharmD, BCPS Clinical Pharmacy Specialist, Cardiac Surgery September 18, 2012 [email protected] This presentation will discuss unlabeled and investigational use of products The author
To implement the program into full execution, an organizing committee and clinical faculty were established, consisting of:
1 st POST GRADUATE COURSE IN CRITICAL CARE PHARMACY COURSE DESCRIPTION The 1 st Post Graduate Course on Critical Care Pharmacy is a three-day program designed for pharmacists in hospital settings who provide
Anticoagulant therapy
Anticoagulation: The risks Anticoagulant therapy 1990 2002: 600 incidents reported 120 resulted in death of patient 92 deaths related to warfarin usage 28 reports related to heparin usage Incidents in
UHealth Pharmacy Mission & Vision
UHealth Pharmacy Mission & Vision Our Mission The mission of the department of pharmacy services is to deliver the highest-level pharmaceutical services through safe medication practices, innovative research,
THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT
THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological
Service Specification Template Department of Health, updated June 2015
Service Specification Template Department of Health, updated June 2015 Service Specification No. : 2 Service: Commissioner Lead: Provider Lead: Period: Anti-coagulation monitoring Date of Review: 31 st
How To Become A Nurse Practitioner
Carlene A. McAleer, RN, MS, MSN, CRNP, DNP 215-527-1961 [email protected] EDUCATION 2013 Doctorate of Nursing Practice Temple University, Philadelphia, Pennsylvania Capstone: The Association of Prescribed
Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.
Inpatient Anticoagulation Safety Purpose: Policy: To provide safe and effective anticoagulation therapy through a collaborative approach. Upon the written order of a physician, Heparin, Low Molecular Weight
Failure or significant adverse effects to all of the alternatives: Eliquis and Xarelto
This policy has been developed through review of medical literature, consideration of medical necessity, generally accepted medical practice standards, and approved by the IEHP Pharmacy and Therapeutics
Master's Clinical Pharmacy (Thesis Track)
Master's Clinical Pharmacy (Thesis Track) I. GENERAL RULES CONDITIONS: Plan Number 3 \ 12 06 2010 T 1. This plan conforms to the valid regulations of the programs of graduate studies. 2. Areas of specialty
Basic Ingredients of the CHCC PGY-1 Pediatric Pharmacy Residency Program
Basic Ingredients of the CHCC PGY-1 Pediatric Pharmacy Residency Program Pediatric Pharmacy Residency Program (PGY1) Children s Hospital Central California offers a one-year, postgraduate residency program
Prescriber Guide. 20mg. 15mg. Simply Protecting More Patients. Simply Protecting More Patients
Prescriber Guide 20mg Simply Protecting More Patients 15mg Simply Protecting More Patients 1 Dear Doctor, This prescriber guide was produced by Bayer Israel in cooperation with the Ministry of Health as
Lippincott Professional Development Categories
Lippincott Professional Development is a library of e-courses, available for institutional sale, which has been grouped together by subject matter or discipline. Developed to advance clinical and professional
Anticoagulants. Anticoagulants Definition. When are blood clots GOOD? Where and why do blood clots occur? 6/12/2014
Anticoagulants Steven R. Kayser, PharmD Professor Emeritus Department of Clinical Pharmacy UCSF Anticoagulants Definition A substance that hinders the clotting of blood Sometimes referred to as blood thinners
Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media
News Release Not intended for U.S. and UK Media Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer Forms Collaboration with Academic and Governmental Institutions for Rivaroxaban
Dabigatran (Pradaxa) Guidelines
Dabigatran (Pradaxa) Guidelines Dabigatran is a new anticoagulant for reducing the risk of stroke in patients with atrial fibrillation. Dabigatran is a direct thrombin inhibitor, similar to warfarin, without
University of Louisville Hospital PGY1 Pharmacy Residency Program Summary
University of Louisville Hospital PGY1 Pharmacy Residency Program Summary Positions Available: 4 positions, 12 month contract Application Deadline: Early January (see PhORCAS) Requirements: On-site Interview,
With unrestricted educational grant from
HOTEL MAKSOUD PLAZA SÃO PAULO SP BRASIL OCTOBER 22-23, 2009 Organization With unrestricted educational grant from As the President of the Brazilian Society of Internal Medicine and the Brazilian Clinical
Investor News. Not intended for U.S. and UK media
Investor News Not intended for U.S. and UK media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer s Xarelto (Rivaroxaban) Approved for the Treatment of Pulmonary Embolism
Critical Bleeding Reversal Protocol
Critical Bleeding Reversal Protocol Coagulopathy, either drug related or multifactorial, is a major contributing factor to bleeding related mortality in a variety of clinical settings. Standard therapy
Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors
News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients
CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014
CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014 e 55 0495 2 Emergency Department (ED)- 1 Emergency Department Throughput Median time from
Building a Safe Anticoagulation Program By knowing that Safety is not about numbers, Safety is about an attitude..
Building a Safe Anticoagulation Program By knowing that Safety is not about numbers, Safety is about an attitude.. Speakers: Sue Dawson, MA, RN, CCRP Clinical Specialist-Cardiology Cam F. Campbell, M.D.
ANTIBIOTICS IN SEPSIS
ANTIBIOTICS IN SEPSIS Jennifer Curello, PharmD, BCPS Clinical Pharmacist, Infectious Diseases Antimicrobial Stewardship Program Ronald Reagan UCLA Medical Center October 27, 2014 The power of antibiotics
Elective Experiences Roosevelt University Teaching Certificate
Purpose Develop skills in health-system pharmacy management Develop competence in managerial, financial, and organizational components of health-system pharmacy Develop effective organizational, integrative,
Curriculum Vitae. Luci A. Power. Education: M.S. Hospital Pharmacy, 1977 Northeastern University, Boston, Massachusetts
Curriculum Vitae Luci A. Power Education: M.S. Hospital Pharmacy, 1977 Northeastern University, Boston, Massachusetts Licensure: California, 1978 Experience: B.S. Pharmacy, 1969 Northeastern University,
How To Treat Aneuricaagulation
Speaker Introduction Jessica Wilhoite, PharmD, BCACP Doctor of Pharmacy: Purdue University Postgraduate Residency Training: PGY1 Pharmacy Practice St. Vincent Hospital PGY2 Ambulatory Care St. Vincent
Jonathan (Jay) Jackson, PharmD 901 S. Flagler Drive (561) 803-2714
Jonathan (Jay) Jackson, PharmD 901 S. Flagler Drive (561) 803-2714 West Palm Beach, FL 33416 [email protected] Education 2008 2012 Lloyd L. Gregory School of Pharmacy Doctor of Pharmacy Palm Beach
PGY-1 PHARMACY RESIDENCY
PGY-1 PHARMACY RESIDENCY PGY-1 Match Number: 135413 Program Description and Requirements Providence Health System (PAMC) in Anchorage consists of 394 acute care beds and is part of an integrated health
Investor News. Phase III J-ROCKET AF Study of Bayer s Xarelto (rivaroxaban) Meets Primary Endpoint. Not intended for U.S.
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Phase III J-ROCKET AF Study of Bayer s Xarelto (rivaroxaban) Meets Primary Endpoint
New Anticoagulants: What to Use What to Avoid
New Anticoagulants: What to Use What to Avoid Bruce Davidson, MD, MPH Clinical Professor of Medicine Pulmonary and Critical Care Medicine Division University of Washington School of Medicine Seattle USA
CURRICULUM VITAE. BSN Nursing 1991 University of Massachusetts, Boston, MA
CURRICULUM VITAE Name: Eileen Allosso, MS, APRN, BC, CNRN, SCRN, CCM 9 Arborwood Drive Burlington, MA 01803 [email protected] 781-365-0789 Education: M.S. Nursing Family Nurse Practitioner 2005
Session 3 Topics. Argatroban. Argatroban. Drug Use and Adverse Effects. Laboratory Monitoring of Anticoagulant Therapy
~~Marshfield Labs Presents~~ Laboratory Monitoring of Anticoagulant Therapy Session 3 of 4 Michael J. Sanfelippo, M.S. Technical Director, Coagulation Services Session 3 Topics Direct Thrombin Inhibitors:
Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of
F.E.E.A. FONDATION EUROPEENNE D'ENSEIGNEMENT EN ANESTHESIOLOGIE FOUNDATION FOR EUROPEAN EDUCATION IN ANAESTHESIOLOGY
créée sous le Patronage de l'union Européenne Detailed plan of the program of six courses 1. RESPIRATORY 1. ESPIRATORY AND THORAX 1.1 Physics and principles of measurement 1.1.1 Physical laws 1.1.2 Vaporizers
ACROSS THE CONTINUUM: Optimizing Strategies for Acute to Chronic Pain Management HEALTH-SYSTEM PHARMACIST PERSPECTIVES AGENDA
Optimizing Strategies for Acute to Chronic Pain Management AGENDA 11:30 11:45 AM Conference Goals/Pre-Test J. Richard Brown, PharmD, FASHP 11:45 12:00 PM The Pain Continuum: From Acute Treatment to Chronic
Backgrounder. Current anticoagulant therapies
Backgrounder Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Current anticoagulant therapies Anticoagulant drugs have significantly reduced the risk of thromboembolic events
Speaker Disclosure. Outline. Pharmacist Objectives. Patient Case. Outline 9/4/2014
Speaker Disclosure Matthew K. Pitlick, Pharm.D., BCPS St. Louis College of Pharmacy/VA St. Louis HCS [email protected] Matthew K. Pitlick, Pharm.D., BCPS declares no conflicts of interest, real or apparent,
A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation
Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation PATIENT EDUCATION GUIDE What is atrial fibrillation? Atrial fibrillation
May 20, 2016. May 21, 2016. The 5th Annual Comprehensive Stroke and Neurocritical Care Symposium. Comprehensive Stroke Symposium
The 5th Annual Comprehensive Stroke and Neurocritical Care Symposium May 20, 2016 Comprehensive Stroke Symposium May 21, 2016 Emergency Neurological Life Support Course and Certification The Richmond Marriott
The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38
Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac
Rx Updates New Guidelines, New Medications What You Need to Know
Rx Updates New Guidelines, New Medications What You Need to Know Maria Pruchnicki, PharmD, BCPS, BCACP, CLS Associate Professor of Clinical Pharmacy OSU College of Pharmacy Background scope and impact
Tampa General Hospital s Pharmacy Residency Program
s Pharmacy Residency Program Preceptor Profiles Earnest Alexander, Jr., PharmD, FCCM PGY2 Critical Care Residency Director Assistant Director, Clinical Pharmacy Services Dr. Alexander earned his PharmD
New Real-World Evidence Reaffirms Low Major Bleeding Rates for Bayer s Xarelto in Patients with Non-Valvular Atrial Fibrillation
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Late-Breaking Science at ESC Congress 2015: New Real-World Evidence Reaffirms
CURRICULUM VITAE. 1967-1971 B.S. cum laude, Biology Rhodes University (prior Southwestern at Memphis) Memphis, TN
April, 2015 Employee # 190394 NAME: Stephen Paul Busby, MD CURRICULUM VITAE BIOGRAPHICAL DOB: 08/30/49 Place of Birth: Memphis, TN Citizenship: USA Home Address: 4502 S. Flamingo Dr., Seabrook, TX 77586
Actionable Insights into Health Policy, Practice and Outcomes Through Research and Big Data - with a Spotlight on Oncology
Actionable Insights into Health Policy, Practice and Outcomes Through Research and Big Data - with a Spotlight on Oncology Attend the Virtual Meeting in HE-Xpo Wednesday, Feb. 18, 2015 Session One: 9:30
New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding - A Systematic Review and Meta-Analysis
New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding - A Systematic Review and Meta-Analysis Holster IL, Valkhoff VE, Kuipers EJ, Tjwa ET Departments of Gastroenterology and Hepatology,
Physician Assistant Program
Master of Science (M.Sc.), http://chp.cmich.edu/pa Degree Requirements for PA Students First Year - Summer (15 hours) HSC 630 - Regional Human Anatomy 5(3-4) PHA 624 - Issues in Practice 2(2-0) PHA 633
Pharmacy Practice Residency Preceptors
Pharmacy Practice Residency Preceptors Vincent A. Lacroce, Pharm.D, Vince has been on staff at Pennsylvania State University Hospital, the Milton S. Hershey Medical Center since January of 1985 in various
STROKE PREVENTION IN ATRIAL FIBRILLATION
STROKE PREVENTION IN ATRIAL FIBRILLATION OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention of ischemic stroke and arterial thromboembolism in patients
How To Understand The History Of Analgesic Drugs
New Developments in Oral Anticoagulants: Treating and Preventing Embolic Events in the 21 st Century David Stewart, PharmD, BCPS Associate Professor of Pharmacy Practice East Tennessee State University
EDUCATION REGISTRATION. Connecticut RN E43803 and APRN license 28287 PROFESSIONAL EXPERIENCE
Paula S. McCauley DNP APRN ACNP-BC CNE Associate Dean for Academic Affairs/Associate Clinical Professor/Acute Care Track Coordinator Acute Care Nurse Practitioner Critical Care University of Connecticut
NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl
NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl Mikele Wissing, RN June 2014 Introduction until recently, was the unrivaled medication for treatment
Venous Thromboembolic Treatment Guidelines
Venous Thromboembolic Treatment Guidelines About the NYU Venous Thromboembolic Center (VTEC) The center s mission is to deliver advanced screening, detection, care, and management services for patients
Disclosure. Meaningful use 2009. Objectives. Meaningful use. Fundamentals of Transitions of Care (TOC)
47 th Annual Meeting August 2-4, 2013 Orlando, FL Fundamentals of Transitions of Care (TOC) Rebecca R. Prevost, B.S., Pharm.D., PSO Medication Safety Officer Florida Hospital Disclosure I do not have a
How To Get A Dose Of Bayer Healthcare'S Oral Anticoagulant, Xarelto
News Release FOR UK HEALTHCARE MEDIA ONLY Bayer HealthCare Bayer plc Bayer House Strawberry Hill Newbury Berkshire, RG14 1JA www.bayer.co.uk Bayer s Xarelto (rivaroxaban) Recommended by CHMP for EU Approval
Stroke/VTE Quality Measure Build for Meaningful Use Stage 1
Stroke/VTE Quality Measure Build for Meaningful Use Stage 1 Presented by Susan Haviland, BSN RN Senior Consult, Santa Rosa Consulting Meaningful Use Quality Measures Centers for Medicare and Medicaid Services
Christopher Betz, Pharm.D., BCPS
Christopher Betz, Pharm.D., BCPS Associate Professor Sullivan University College of Pharmacy Internal Medicine Clinical Pharmacy Specialist Norton Audubon Hospital Louisville, Kentucky Christopher Betz,
Northeast Ohio Medical University (NEOMED) Chair of Pharmaceutical Sciences Search
Northeast Ohio Medical University (NEOMED) Chair of Pharmaceutical Sciences Search Spring 2013 About NEOMED Northeast Ohio Medical University (NEOMED) www.neomed.edu is a dynamic free-standing community-based,
Anticoagulation Therapy Update
Anticoagulation Therapy Update JUDY R. WALLING, FNP-BC ARRHYTHMIA MANAGEMENT MUSC CARDIOLOGY Outline Who do we anticoagulate? Review classes of Anticoagulants Review examples of Anticoagulants Review CHADS2
STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND:
STROKE PREVENTION IN ATRIAL FIBRILLATION TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention
Bayer Extends Clinical Investigation of Xarelto for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer Extends Clinical Investigation of Xarelto for the Prevention and Treatment
Anticoagulation and Reversal
Anticoagulation and Reversal John Howard, PharmD, BCPS Clinical Pharmacist Internal Medicine Affiliate Associate Clinical Professor South Carolina College of Pharmacy Disclosures I have no Financial, Industry,
STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE
STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE CASE REPORT: ACUTE STROKE MANAGEMENT 90 YEAR OLD WOMAN, PREVIOUSLY ACTIVE AND INDEPENDENT, CHRONIC ATRIAL FIBRILLATION,
Curriculum vitae. (Honors) 1999 M.B.B.S Medical School Al-Ameen Medical College, Bijapur, Karnataka, India.
Curriculum vitae Name: Office Address: Zubair A Syed, MD 5920 Forest Park Road. (6 th Floor) Dallas, Texas, 75390-9165 Work Phone: (214) 648-4128 Work E-Mail: [email protected] Work Fax: 214-358-3708
LAMC Reversal Agent Guideline for Anticoagulants 2013. Time to resolution of hemostasis (hrs) Therapeutic Options
LAMC Reversal Agent Guideline for Anticoagulants 2013 Medication resolution of hemostasis (hrs) Intervention Administration Instructions Heparin 3-4 Protamine 1mg IV for every 100 units of heparin Slow
Blood products and pharmaceutical emergencies
Blood products and pharmaceutical emergencies Kasey L. Bucher PharmD, BCPS Clinical Specialist, Emergency Medicine Mercy Health Saint Mary s September 12, 2013 Disclosures None significancemagazine.com
ACCP MODEL PRACTICE. A Pharmacist-Staffed Inpatient Antithrombosis Service. American College of Clinical Pharmacy. William E. Dager, Pharm.D.
ACCP MODEL PRACTICE A Pharmacist-Staffed Inpatient Antithrombosis Service American College of Clinical Pharmacy William E. Dager, Pharm.D. a a Pharmacist Specialist, University of California Davis Medical
Danielle M. Miller, PharmD, RPh. 360 Huntington Avenue, X120TF 850 Harrison Avenue. Tel: 617-373-2531 Boston, Massachusetts 02118
Danielle M. Miller, PharmD, RPh University Contact Information: Practice Site Contact Information: Northeastern University Boston Medical Center 360 Huntington Avenue, X120TF 850 Harrison Avenue 02115
Bakersfield College Associate Degree Nursing NURS B28 - Medical Surgical Nursing 4
1 Bakersfield College Associate Degree Nursing NURS B28 - Medical Surgical Nursing 4 Unit 1 - COURSE This unit will present the instructional syllabus and define the Student Learning Outcomes (SLO) for
